GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Frontage Holdings Corp (HKSE:01521) » Definitions » Price-to-Owner-Earnings

Frontage Holdings (HKSE:01521) Price-to-Owner-Earnings : 11.45 (As of May. 16, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Frontage Holdings Price-to-Owner-Earnings?

As of today (2024-05-16), Frontage Holdings's share price is HK$1.26. Frontage Holdings's Owner Earnings per Share (TTM) ended in Dec. 2023 was HK$0.11. It's Price-to-Owner-Earnings for today is 11.45.


The historical rank and industry rank for Frontage Holdings's Price-to-Owner-Earnings or its related term are showing as below:

HKSE:01521' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 9.13   Med: 26.97   Max: 79.22
Current: 11.45

During the past 8 years, the highest Price-to-Owner-Earnings of Frontage Holdings was 79.22. The lowest was 9.13. And the median was 26.97.


HKSE:01521's Price-to-Owner-Earnings is ranked better than
84.52% of 168 companies
in the Biotechnology industry
Industry Median: 34.045 vs HKSE:01521: 11.45

As of today (2024-05-16), Frontage Holdings's share price is HK$1.26. Frontage Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.04. Therefore, Frontage Holdings's PE Ratio for today is 31.50.

As of today (2024-05-16), Frontage Holdings's share price is HK$1.26. Frontage Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was HK$0.09. Therefore, Frontage Holdings's PE Ratio without NRI for today is 13.85.

During the past 8 years, Frontage Holdings's highest PE Ratio without NRI was 108.80. The lowest was 13.26. And the median was 37.41.


Frontage Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for Frontage Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frontage Holdings Price-to-Owner-Earnings Chart

Frontage Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - 41.65 44.38 14.80 21.09

Frontage Holdings Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.38 - 14.80 - 21.09

Competitive Comparison of Frontage Holdings's Price-to-Owner-Earnings

For the Biotechnology subindustry, Frontage Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Frontage Holdings's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Frontage Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Frontage Holdings's Price-to-Owner-Earnings falls into.



Frontage Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Frontage Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1.26/0.11
=11.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Frontage Holdings  (HKSE:01521) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Frontage Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Frontage Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Frontage Holdings (HKSE:01521) Business Description

Traded in Other Exchanges
Address
700 Pennsylvania Drive, Exton, PA, USA, 19341
Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical and development services. Geographically the group operates in both PRC and North America. The services provided in the North American segment, include Bioanalytical, CMC, DMPK and Safety and Toxicology services in the USA and Canada. The service offered in PRC includes Bioanalytical, Bioequivalence and CMC services in the PRC. Further, it also provides bioanalytical services, which are offered throughout the drug discovery and development process both in the United States and China.

Frontage Holdings (HKSE:01521) Headlines

No Headlines